|

CS231295 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Chipscreen Biosciences, Ltd.1

Indications

  • Small Cell Lung Carcinoma (SCLC)1
  • Glioblastoma, Adult1
  • Neoplasms1
  • Lung Cancer1
  • Cancer1

Other1 trial

Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.